IFN-GAMMA DECREASES TRANSLOCATION AND IMPROVES SURVIVAL FOLLOWING TRANSFUSION AND THERMAL-INJURY

被引:29
作者
GENNARI, R
ALEXANDER, JW
EAVESPYLES, T
机构
[1] UNIV CINCINNATI,MED CTR,DEPT SURG,DIV TRANSPLANTAT,CINCINNATI,OH 45267
[2] SHRINERS BURNS INST,CINCINNATI,OH 45267
关键词
D O I
10.1006/jsre.1994.1085
中图分类号
R61 [外科手术学];
学科分类号
摘要
The effects of recombinant murine interferon-gamma (rmIFN-gamma) on survival and host defense were studied during gut-derived sepsis that included transfusion-induced immunosuppression. Balb/c mice (n = 153) were transfused with allogeneic blood and then treated with different doses of rmIFN-gamma: 10, 100, 1000, 10,000 U, or sterile saline as control once daily for 3 days. Five days after transfusion they were gavaged with 10(10) Escherichia coli and given a 20% TBSA burn injury. Survival was significantly higher in groups receiving 10 U compared to control and the group receiving 10,000 U (P < 0.0001 and P = 0.02, respectively). Groups receiving 100 or 1000 U also showed an improvement of survival compared to nontreated control animals (P = 0.02). The effect of rmIFN-gamma on the degree of translocation and the host's ability to kill translocated organisms was also investigated. Mice were treated as described above, except they were gavaged with In-111 oxine-labeled E. coli and then subjected to a 20% TBSA burn. Mesenteric lymph nodes (MLN), liver, and spleen were harvested aseptically. Less translocation to the liver was observed compared to the nontreated group (P = 0.002) to the MLNs and spleen of the group treated with 100 U rmIFN-gamma compared to controls and the group treated with 10 U (P < 0.005). Animals receiving 1000 U showed fewer bacteria in the liver and spleen compared to the control group (P < 0.005). Moreover, the ability to kill translocated organisms was significantly enhanced in the liver of the animals receiving 10 or 100 U rmIFN-gamma compared to all other groups (P < 0.0001). In conclusion, the study suggests that treatment with 10 and 100 U of rmIFN-gamma positively affects the outcome in gut-derived sepsis, mainly by enhancing killing of translocated bacteria. The beneficial effect in animals receiving 100 or 1000 U was related to an improved gut barrier function. (C) 1994 Academic Press, Inc.
引用
收藏
页码:530 / 536
页数:7
相关论文
共 44 条
[1]  
ADAMS RB, 1993, J IMMUNOL, V150, P2356
[2]   DISTRIBUTION AND SURVIVAL OF ESCHERICHIA-COLI TRANSLOCATING FROM THE INTESTINE AFTER THERMAL-INJURY [J].
ALEXANDER, JW ;
GIANOTTI, L ;
PYLES, T ;
CAREY, MA ;
BABCOCK, GF .
ANNALS OF SURGERY, 1991, 213 (06) :558-567
[3]   THE PROCESS OF MICROBIAL TRANSLOCATION [J].
ALEXANDER, JW ;
BOYCE, ST ;
BABCOCK, GF ;
GIANOTTI, L ;
PECK, MD ;
DUNN, DL ;
PYLES, T ;
CHILDRESS, CP ;
ASH, SK .
ANNALS OF SURGERY, 1990, 212 (04) :496-512
[4]  
BALKWILL FR, 1989, CYTOKINES CANCER
[6]  
BROWDER W, 1990, ANN SURG, V211, P605
[7]   MOUSE FIBROBLAST INTERFERON MODIFIES SALMONELLA-TYPHIMURIUM INFECTION IN INFANT MICE [J].
BUKHOLM, G ;
BERDAL, BP ;
HAUG, C ;
DEGRE, M .
INFECTION AND IMMUNITY, 1984, 45 (01) :62-66
[8]  
Deitch E A, 1987, J Burn Care Rehabil, V8, P475, DOI 10.1097/00004630-198708060-00005
[9]  
DELLINGER EP, 1984, ARCH SURG-CHICAGO, V119, P20
[10]   PARTIAL CORRECTION OF THE PHAGOCYTE DEFECT IN PATIENTS WITH X-LINKED CHRONIC GRANULOMATOUS-DISEASE BY SUBCUTANEOUS INTERFERON-GAMMA [J].
EZEKOWITZ, RAB ;
DINAUER, MC ;
JAFFE, HS ;
ORKIN, SH ;
NEWBURGER, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :146-151